Enovis (ENOV), a global medical technology company, Friday, announced that Davide Visentin will take over as President of Enovis International Surgical, effective March 1.
Visentin succeeds Benjamin Reinmann, who has played a pivotal role in shaping the company's International Surgical Business.
Most recently, Visentin served as Vice President and General Manager of the Integrated Diagnostic Solutions Business Unit at BD.
ENOV is currently trading at $46.70 up 2.71 percent or $1.23 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.